Drug Discovery Unchained: What The Drug!? #2

webinar

Wed, 14 Aug 2024, 16:00 CEST (Berlin)

Dr. Alexander Neumann, BioSolveIT, Germany

Drug Discovery Unchained: What The Drug!? #2

What happens when somebody asks you to do drug discovery? No preparation, no script, no nothing. Just live performing and sharing your thoughts.

This is “What The Drug!?”: a live session tackling a drug discovery challenge using BioSolveIT tools, with the aim of reaching a conclusion in a reasonable time frame. What is the challenge? We do not know. Everything will be revealed during the stream, and we will see how things unfold.

The first session was a good starting point, but let’s see how things develop. Dive into the session, discuss together, and explore on-the-fly compound design.

Current news

category
Events
Workshop: Next Generation of Compound Catalogs: Trillion-Sized eXplore Chemical Space @ San Diego
April 1, 2025 16:00 CEST
We are excited to announce a collaborative workshop between BioSolveIT and eMolecules, focusing on the Trillion-Sized eXplore Chemical Space. This hands-on session is designed for drug discovery enthusiasts eager to dive into the vast potential of ultra-large compound collections.​ Event Details: Date: Tuesday, April 15, 2025​ Time: 5:00 PM –...
Read on
Enamine’s REAL Space March 2025 Update - Now 76 Billion!
March 27, 2025 13:00 CET
The March 2025 update of Enamine’s REAL Space brings a new expansion — now featuring over 76 billion accessible, drug-like products, up from 70 billion in the previous release. With 172 curated reactions and 182,038 reagents and building blocks based on in-house knowledge, this version further enhances one of the...
Read on
CHEMriya Space Update: 55 Billion Molecules Unlocking New Frontiers in Drug Discovery!
March 13, 2025 14:00 CET
We are excited to announce a major update to OTAVA’s CHEMriya™ Chemical Space, now featuring 55 billion accessible molecules built upon 323 in-house reactions. With the March 2025 update, several new reactions have been added to the chemistry portfolio, expanding the space by over 43 billion novel molecules. This significant...
Read on